OXLUMO® (lumasiran)
Full Prescribing Information for OXLUMO® (lumasiran)
Click below to learn more about the use of lumasiran in pediatric and adult patients with primary hyperoxaluria type 1 (PH1).
If you require any further information on lumasiran, please connect with us by reaching out to your local Medical Science Liaison or contacting our Medical Information team.
More Information About Lumasiran
For more information about data regarding lumasiran, please visit our Congresses and Publications resource page.
Image
ILLUMINATE Clinical Trial Program Overview
This infographic details the ILLUMINATE clinical trial program which investigates the treatment of Primary Hyperoxaluria Type 1 with lumasiran.
Slide Deck
